Qingfeng Pharmaceutical Group
1 clinical trials · Sponsor
◉ Watch Qingfeng Pharmaceutical Group
| Record | Firm | Date |
|---|---|---|
| Adjunctive Therapy of Andrographolid Sulfonatein Community Acquired Pneumonia (NCT02913118) | Qingfeng Pharmaceutical Group | 2016-07-01 |
Track Qingfeng Pharmaceutical Group automatically
Every clearance here is in the API, with alerts when new ones post.